Literature DB >> 18989114

Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy.

Keith A Josephs1, Joseph R Duffy.   

Abstract

PURPOSE OF REVIEW: To highlight the fact that patients with corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) can sometimes present with a progressive apraxia of speech, nonfluent aphasia, or a combination of the two disorders. RECENT
FINDINGS: Corticobasal degeneration and PSP are neurodegenerative diseases characterized by neuronal loss and gliosis in cardinal brain regions, as well as the abnormal deposition of the microtubule associated protein tau in cell bodies and cell processes. The typical presenting features of CBD and PSP are akinesia and rigidity that are levodopa unresponsive, although there has been evidence that both diseases, moreso CBD, can present with a dementia syndrome. Recent clinicopathological studies have now also demonstrated that a subset of patients with CBD and PSP present with a progressive apraxia of speech, nonfluent aphasia, or a combination of the two disorders.
SUMMARY: Presenting features of progressive apraxia of speech or nonfluent aphasia are strongly associated with a diagnosis of CBD, PSP, or both.

Entities:  

Mesh:

Year:  2008        PMID: 18989114     DOI: 10.1097/WCO.0b013e3283168ddd

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  52 in total

1.  Parkinsonism and frontotemporal dementia: the clinical overlap.

Authors:  Alberto J Espay; Irene Litvan
Journal:  J Mol Neurosci       Date:  2011-09-03       Impact factor: 3.444

2.  Slowly progressive aphemia: a neuropsychological, conventional, and functional MRI study.

Authors:  R Gallassi; L Sambati; R Poda; F Oppi; M Stanzani Maserati; D Cevolani; R Agati; R Lodi
Journal:  Neurol Sci       Date:  2011-05-24       Impact factor: 3.307

3.  Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy.

Authors:  Farwa Ali; Peter R Martin; Hugo Botha; J Eric Ahlskog; James H Bower; Joseph Y Masumoto; Demetrius Maraganore; Anhar Hassan; Scott Eggers; Bradley F Boeve; David S Knopman; Daniel Drubach; Ronald C Petersen; Erika Driver Dunkley; Jay van Gerpen; Ryan Uitti; Jennifer L Whitwell; Dennis W Dickson; Keith A Josephs
Journal:  Mov Disord       Date:  2019-02-06       Impact factor: 10.338

Review 4.  Differentiation of atypical Parkinson syndromes.

Authors:  Günter U Höglinger; Jan Kassubek; Ilona Csoti; Reinhard Ehret; Heinz Herbst; Ingmar Wellach; Jürgen Winkler; Wolfgang H Jost
Journal:  J Neural Transm (Vienna)       Date:  2017-02-27       Impact factor: 3.575

5.  Non-right handed primary progressive apraxia of speech.

Authors:  Hugo Botha; Joseph R Duffy; Jennifer L Whitwell; Edythe A Strand; Mary M Machulda; Anthony J Spychalla; Nirubol Tosakulwong; Matthew L Senjem; David S Knopman; Ronald C Petersen; Clifford R Jack; Val J Lowe; Keith A Josephs
Journal:  J Neurol Sci       Date:  2018-05-07       Impact factor: 3.181

6.  Clinical Progression in Four Cases of Primary Progressive Apraxia of Speech.

Authors:  Rene L Utianski; Joseph R Duffy; Heather M Clark; Edythe A Strand; Sarah M Boland; Mary M Machulda; Jennifer L Whitwell; Keith A Josephs
Journal:  Am J Speech Lang Pathol       Date:  2018-11-21       Impact factor: 2.408

7.  The Apraxia of Speech Rating Scale: a tool for diagnosis and description of apraxia of speech.

Authors:  Edythe A Strand; Joseph R Duffy; Heather M Clark; Keith Josephs
Journal:  J Commun Disord       Date:  2014-07-14       Impact factor: 2.288

Review 8.  Language, executive function and social cognition in the diagnosis of frontotemporal dementia syndromes.

Authors:  Michał Harciarek; Stephanie Cosentino
Journal:  Int Rev Psychiatry       Date:  2013-04

Review 9.  Clinical diagnostic criteria and classification controversies in frontotemporal lobar degeneration.

Authors:  Katya Rascovsky; Murray Grossman
Journal:  Int Rev Psychiatry       Date:  2013-04

10.  Apraxia in progressive nonfluent aphasia.

Authors:  Jonathan Daniel Rohrer; Martin N Rossor; Jason D Warren
Journal:  J Neurol       Date:  2009-11-12       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.